
A progesterone vaginal insert has been OK'd for marketing and will be sold under the name Endometrin, from Ferring Pharmaceuticals. The new formulation will be available in a100-mg strength and is indicated to support embryo implantation and early pregnancy by supplementation of corpus luteal function as part of an assisted reproductive technology treatment for infertile women.

















